Navigation Links
Failure of heart drug offers lessons for drug industry

Madison, Wis. - Pfizer spent about $800 million to develop torcetrapib, a heart drug that seemed like a blockbuster until people began to die in clinical trials. Hours after learning the drug was irreversibly flawed, the company called a halt to further trials, a decision that sent its stock downward and put thousands of job......

Full article >>> elatively few useful drugs.

Tufts luck

Consider a recent study by Tufts University, which examined the cost of producing biotechnology drugs. Unlike prescription drugs that are made with synthetic chemicals, biotech drugs are derived from substances occurring naturally in the human body or in other living organisms. This is a sweet spot f......

Full article >>> at may be the first major contribution of human embryonic stem cell research. Animal tests generally work well, but tests employing stem cells and biomarkers could dramatically increase accuracy - and weed out dangerous drugs earlier.

That's not to say drugs will ever be cheap so far as consumers are concerned. The search for new medicines is a process that will continue to be costly, mai......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 12/12/06


Related biology technology :

1. Router Failure and Software Crash UW-Madison Network
2. Primary cells, rat heart endothel
3. Primary cells, rat heart muscle
4. UW tests adult stem cell role in regenerative heart care
5. InvivoSciences receives NIH grant for heart technology
6. FDA approves GEs heart-imaging technology
7. Biotech firm uses live heart tissue in drug screens
8. Aurora team implants Wisconsins first total artificial heart
9. Medical College researchers receive new grants to enhance discovery of heart-protecting anesthetics
10. UW-Madison puts heart and mind into stem cells
11. Technology helps heal heart arrhythmias in children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Colo. , March 23, 2017  GlobeImmune, Inc. ... agreement for the sale of 12,835,490 shares of its ... NantWorks  ecosystem of companies. In connection with the sale of ... $100,000 in cash and issue to GlobeImmune 200,000 shares, ... stock. "We are pleased to enter ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... ... causes of death, putting significant strain on health care systems, ... of cancer diagnoses rises, so too does the development of ... with minimum side effects. Among the many types of cancer ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced ... the hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business ... joint development activities. , “Dr. Floyd’s career has spanned 30 years in the ...
(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
Breaking Biology Technology:
(Date:3/20/2017)... ALLENTOWN, Pa. , March 20, 2017 ... PD 2.0 personal spirometer and Wellness Management System (WMS), ... Founded in 2010, PMD Healthcare is a ... Company with a mission dedicated to creating innovative solutions ... of life. With that intent focus, PMD developed the ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today announces that it ... insights to support its reporting, help direct future campaigns, and share ... charity will be using Brandwatch Analytics social listening and analytics technology ... the topics and issues that are a priority for its supporters. ... "Until recently we,ve ...
(Date:3/2/2017)... LONDON , March 2, 2017 Who ... infringement lawsuits? Download the full report: https://www.reportbuyer.com/product/4313699/ ... ON THE FINGERPRINT SENSOR FIELD? Fingerprint sensors using ... smartphones. The fingerprint sensor vendor Idex forecasts an increase ... in mobile devices and of the fingerprint sensor market ...
Breaking Biology News(10 mins):